Viewing Study NCT00301756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-22 @ 8:31 AM
Study NCT ID: NCT00301756
Status: COMPLETED
Last Update Posted: 2018-08-20
First Post: 2006-03-09
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Carcinoma View
None Primary Peritoneal Carcinoma View
None Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor View
None Recurrent Ovarian Carcinoma View
None Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor View
None Stage III Ovarian Cancer View
None Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor View
None Stage IV Ovarian Cancer View
Keywords: